Rapidly mainstreaming breakthrough medical research, sometimes called "bench to bedside," has become a bipartisan priority. The rapid development and dissemination of COVID-19 vaccines established a new focus on how lives can be saved and improved if regulatory pathways, research resources, and the medical professional acceptance were better aligned.
Here is a fascinating story recently printed in the Wall Street Journal of just this use by a brilliant physician in the 1930s who used plasma to prevent diseases before suitable vaccines existed.
A New Lancet study shows BPA levels, a chemical used in many plastic products such as food and drink containers, are much higher than previously thought. BPA interferes with hormones, and in unborn babies has been connected to metabolism, behavior, cancer growth, and other problems.
If you're one of the millions who rely on medications known as proton pump inhibitors for relief from heartburn, you may be at higher risk of illness from a stomach bug, new research suggests. Proton pump inhibitors (PPIs) include medications such as Nexium, Prevacid, Protonix and Prilosec. The study from France found that people who took these acid-relieving medications were about 80% more likely to get a bout of stomach flu. The findings were published Nov. 27 in JAMA Network Open.
Top scientists have said that the EU’s Clinical Trial Directive is making medicine more expensive and research anti-competitive, while the long delays between trial and prescription are causing patients to "suffer". "The Clinical Trials Directive was put forward in the spirit of harmonisation but was, in fact, a mechanism to make trials so horrendously expensive that only Big Pharma could afford to get their products registered," Professor Dalgleish and Professor Lewis wrote in BrexitCentral on Sunday.
